https://www.selleckchem.com/pr....oducts/XL880(GSK1363
53 [SD, 8.82] minutes and the mean contrast dose was 74.9 [SD, 35.6] mL. A small number of studies met the inclusion criteria, all of them were retrospective, and none compared outcomes with proximal transradial or femoral access. Early experience with distal transradial access suggests that it is a safe and effective alternative to proximal radial and femoral access for performing diagnostic cerebral angiography and interventions. Additional studies are needed to establish its efficacy and compare it with other acce
Like
Comment
Share
